Literature DB >> 21160578

Diagnosis of pancreatic tumors by endoscopic ultrasonography.

Hiroki Sakamoto1, Masayuki Kitano, Ken Kamata, Muhammad El-Masry, Masatoshi Kudo.   

Abstract

Pancreatic tumors are highly diverse, as they can be solid or cystic, and benign or malignant. Since their imaging features overlap considerably, it is often difficult to characterize these tumors. In addition, small pancreatic tumors, especially those less than 2 cm in diameter, are difficult to detect and diagnose. For characterizing pancreatic tumors and detecting small pancreatic tumors, endoscopic ultrasonography (EUS) is the most sensitive of the imaging procedures currently available. This technique also provides good results in terms of the preoperative staging of pancreatic tumors. EUS-guided fine needle aspiration (EUS-FNA) has also proved to be a safe and useful method for tissue sampling of pancreatic tumors. Despite these advantages, however, it is still difficult to differentiate between benign and malignant, solid or cystic pancreatic tumors, malignant neoplasms, and chronic pancreatitis using EUS, even when EUS-FNA is performed. Recently, contrast-enhanced EUS with Doppler mode (CE-EUS) employing ultrasound contrast agents, which indicate vascularization in pancreatic lesions, has been found to be useful in the differential diagnosis of pancreatic tumors, especially small pancreatic tumors. However, Doppler ultrasonography with contrast-enhancement has several limitations, including blooming artifacts, poor spatial resolution, and low sensitivity to slow flow. Consequently, an echoendoscope was developed recently that has a broad-band transducer and an imaging mode that was designed specifically for contrast-enhanced harmonic EUS (CEH-EUS) with a second-generation ultrasound contrast agent. The CEH-EUS technique is expected to improve the differential diagnosis of pancreatic disease in the future. This review describes the EUS appearances of common solid and cystic pancreatic masses, the diagnostic accuracy of EUS-FNA, and the relative efficacies and advantages of CE-EUS and CEH-EUS along with their relative advantages and their complementary roles in clinical practice.

Entities:  

Keywords:  Contrast-enhanced endoscopic ultrasonography; EUS-guided fine needle aspiration; Endoscopic ultrasonography; Pancreas; Sonazoid

Year:  2010        PMID: 21160578      PMCID: PMC2999320          DOI: 10.4329/wjr.v2.i4.122

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  102 in total

1.  Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome.

Authors:  Yasunori Minami; Masatoshi Kudo; Toshihiko Kawasaki; Hobyung Chung; Chikara Ogawa; Hitoshi Shiozaki
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

Review 2.  Small pancreatic lesions: is there need for EUS-FNA preoperatively? What to do with the incidental lesions?

Authors:  H Maguchi; K Takahashi; M Osanai; A Katanuma
Journal:  Endoscopy       Date:  2006-06       Impact factor: 10.093

Review 3.  Tridimensional (3D) endoscopic ultrasound - a pictorial review.

Authors:  Adrian Saftoiu; Dan Ionuţ Gheonea
Journal:  J Gastrointestin Liver Dis       Date:  2009-12       Impact factor: 2.008

4.  Pancreatic cancer: 30 year review (1947 to 1977).

Authors:  K Reed; P C Vose; B S Jarstfer
Journal:  Am J Surg       Date:  1979-12       Impact factor: 2.565

5.  A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion.

Authors:  M S Bhutani; R H Hawes; B J Hoffman
Journal:  Gastrointest Endosc       Date:  1997-06       Impact factor: 9.427

6.  Solitary cystic tumor of the pancreas: EUS-pathologic correlation.

Authors:  K Koito; T Namieno; T Nagakawa; T Shyonai; N Hirokawa; K Morita
Journal:  Gastrointest Endosc       Date:  1997-03       Impact factor: 9.427

7.  EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery.

Authors:  José Celso Ardengh; Gustavo Andrade de Paulo; Angelo Paulo Ferrari
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

8.  EUS in the evaluation of pancreatic cystic lesions.

Authors:  Moon Hee Song; Sung Koo Lee; Myung-Hwan Kim; Hyun Ju Lee; Kyu-Pyo Kim; Hyun Jun Kim; Sang Soo Lee; Dong Wan Seo; Young Il Min
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

9.  Cystic tumors mistaken for pancreatic pseudocysts.

Authors:  A L Warshaw; P L Rutledge
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

10.  Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.

Authors:  John DeWitt; Benedict Devereaux; Melissa Chriswell; Kathleen McGreevy; Thomas Howard; Thomas F Imperiale; Donato Ciaccia; Kathleen A Lane; Dean Maglinte; Kenyon Kopecky; Julia LeBlanc; Lee McHenry; James Madura; Alex Aisen; Harvey Cramer; Oscar Cummings; Stuart Sherman
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

View more
  11 in total

Review 1.  Endoscopic approach to the diagnosis of pancreatic cystic tumor.

Authors:  Yoshiaki Kawaguchi; Tetsuya Mine
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 2.  Imaging pancreatobiliary ductal system with optical coherence tomography: A review.

Authors:  Mohammad S Mahmud; Gray R May; Mohammad M Kamal; Ahmed S Khwaja; Carry Sun; Alex Vitkin; Victor Xd Yang
Journal:  World J Gastrointest Endosc       Date:  2013-11-16

Review 3.  Contrast-enhanced endoscopic ultrasonography in digestive diseases.

Authors:  Yoshiki Hirooka; Akihiro Itoh; Hiroki Kawashima; Eizaburo Ohno; Yuya Itoh; Yosuke Nakamura; Takeshi Hiramatsu; Hiroyuki Sugimoto; Hajime Sumi; Daijiro Hayashi; Naoki Ohmiya; Ryoji Miyahara; Masanao Nakamura; Kohei Funasaka; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

4.  Randomized Controlled Trial Comparing the Usefulness of Endoscopic Ultrasound Processor.

Authors:  Hiroki Koda; Kazuya Matsumoto; Yohei Takeda; Takumi Onoyama; Soichiro Kawata; Hiroki Kurumi; Taro Yamashita; Hisashi Noma; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

5.  Contrast-Enhanced Endoscopic Ultrasonography for Pancreatic Tumors.

Authors:  Yasunobu Yamashita; Jun Kato; Kazuki Ueda; Yasushi Nakamura; Yuki Kawaji; Hiroko Abe; Junya Nuta; Takashi Tamura; Masahiro Itonaga; Takeichi Yoshida; Hiroki Maeda; Takao Maekita; Mikitaka Iguchi; Hideyuki Tamai; Masao Ichinose
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

6.  Clinical role of contrast-enhanced harmonic endoscopic ultrasound in differentiating solid lesions of the pancreas: a single-center experience in Korea.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

7.  Pancreatic cystic lesions: The value of contrast-enhanced endoscopic ultrasound to influence the clinical pathway.

Authors:  Michael Hocke; Xin-Wu Cui; Dirk Domagk; Andre Ignee; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2014-04       Impact factor: 5.628

8.  Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases.

Authors:  Can Xu; Zhaoshen Li; Michael Wallace
Journal:  Diagn Ther Endosc       Date:  2012-11-01

9.  Clinical usefulness of plasma chromogranin a in pancreatic neuroendocrine neoplasm.

Authors:  Woo Hyun Paik; Ji Kon Ryu; Byeong Jun Song; Jaihwan Kim; Joo Kyung Park; Yong-Tae Kim; Yong Bum Yoon
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

10.  Diagnosis and treatment of pancreatic pseudocysts and cystic tumors based on own material and quoted literature.

Authors:  Grzegorz Ćwik; Witold Krupski; Artur Zakościelny; Grzegorz Wallner
Journal:  J Ultrason       Date:  2013-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.